PL358791A1 - Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu - Google Patents

Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu

Info

Publication number: PL358791A1
Authority: PL; Poland
Prior art keywords: phenoxyalkyl; thiazolidinedione; metformin; pharmaceutical composition; type derivative
Prior art date: 2000-08-04

Application number

PL01358791A

Other languages

English (en)

Inventor

Gerard Moinet

Gerard Botton

Didier Mesangeau

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-04

Filing date

2001-07-24

Publication date

2004-08-23

2001-07-24 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2004-08-23 Publication of PL358791A1 publication Critical patent/PL358791A1/pl

Links

XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title 1
229960003105 metformin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL01358791A 2000-08-04 2001-07-24 Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu PL358791A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0010362A FR2812547B1 (fr)	2000-08-04	2000-08-04	Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete

Publications (1)

Publication Number	Publication Date
PL358791A1 true PL358791A1 (pl)	2004-08-23

Family

ID=8853342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01358791A PL358791A1 (pl)	2000-08-04	2001-07-24	Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu

Country Status (19)

Country	Link
US (1)	US20040014797A1 (pl)
EP (1)	EP1305025A1 (pl)
JP (1)	JP2004505915A (pl)
KR (1)	KR20030019470A (pl)
CN (1)	CN1446090A (pl)
AR (1)	AR030309A1 (pl)
AU (1)	AU2001282010A1 (pl)
BR (1)	BR0112915A (pl)
CA (1)	CA2417883A1 (pl)
CZ (1)	CZ2003476A3 (pl)
EC (1)	ECSP034463A (pl)
FR (1)	FR2812547B1 (pl)
HU (1)	HUP0303684A2 (pl)
MX (1)	MXPA03000975A (pl)
NO (1)	NO20030518L (pl)
PL (1)	PL358791A1 (pl)
RU (1)	RU2003105809A (pl)
SK (1)	SK2082003A3 (pl)
WO (1)	WO2002011721A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL376577A1 (pl)	2002-06-17	2006-01-09	Themis Laboratories Private Limited	Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
UA80991C2 (en) *	2002-10-07	2007-11-26		Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
AU2007281433A1 (en) *	2006-08-04	2008-02-07	Nastech Pharmaceutical Company Inc.	Compositions for intranasal delivery of human insulin and uses thereof
WO2008093984A1 (en) *	2007-01-29	2008-08-07	Hanall Pharmaceutical Company. Ltd	N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2749583B1 (fr) *	1996-06-07	1998-08-21	Lipha	Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
TR199903057T2 (xx) *	1997-06-18	2000-04-21	Smithkline Beecham Plc	Diabetin tiazolidinedion ve metformin ile tedavisi.
GB9715295D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment

2000
- 2000-08-04 FR FR0010362A patent/FR2812547B1/fr not_active Expired - Fee Related
2001
- 2001-07-24 PL PL01358791A patent/PL358791A1/pl unknown
- 2001-07-24 CA CA002417883A patent/CA2417883A1/en not_active Abandoned
- 2001-07-24 BR BR0112915-5A patent/BR0112915A/pt not_active Application Discontinuation
- 2001-07-24 SK SK208-2003A patent/SK2082003A3/sk unknown
- 2001-07-24 CZ CZ2003476A patent/CZ2003476A3/cs unknown
- 2001-07-24 HU HU0303684A patent/HUP0303684A2/hu unknown
- 2001-07-24 EP EP01960539A patent/EP1305025A1/en not_active Withdrawn
- 2001-07-24 MX MXPA03000975A patent/MXPA03000975A/es unknown
- 2001-07-24 KR KR1020027018026A patent/KR20030019470A/ko not_active Withdrawn
- 2001-07-24 CN CN01813685A patent/CN1446090A/zh active Pending
- 2001-07-24 JP JP2002517057A patent/JP2004505915A/ja active Pending
- 2001-07-24 WO PCT/EP2001/008512 patent/WO2002011721A1/en not_active Ceased
- 2001-07-24 US US10/343,609 patent/US20040014797A1/en not_active Abandoned
- 2001-07-24 RU RU2003105809/15A patent/RU2003105809A/ru not_active Application Discontinuation
- 2001-07-24 AU AU2001282010A patent/AU2001282010A1/en not_active Abandoned
- 2001-08-03 AR ARP010103708A patent/AR030309A1/es unknown
2003
- 2003-02-03 EC EC2003004463A patent/ECSP034463A/es unknown
- 2003-02-03 NO NO20030518A patent/NO20030518L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20040014797A1 (en)	2004-01-22
NO20030518D0 (no)	2003-02-03
WO2002011721A1 (en)	2002-02-14
HUP0303684A2 (hu)	2004-03-01
SK2082003A3 (en)	2003-07-01
AU2001282010A1 (en)	2002-02-18
FR2812547B1 (fr)	2002-10-31
AR030309A1 (es)	2003-08-20
KR20030019470A (ko)	2003-03-06
NO20030518L (no)	2003-02-03
BR0112915A (pt)	2003-07-08
MXPA03000975A (es)	2003-06-09
CA2417883A1 (en)	2002-02-14
CZ2003476A3 (cs)	2003-06-18
ECSP034463A (es)	2003-03-31
JP2004505915A (ja)	2004-02-26
RU2003105809A (ru)	2004-08-27
FR2812547A1 (fr)	2002-02-08
EP1305025A1 (en)	2003-05-02
CN1446090A (zh)	2003-10-01

Legal Events

Date	Code	Title	Description
2007-10-31	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
ZA200203368B (en)	2003-09-02	Pharmaceutical composition comprising a combination of metformin and glibenclamide.
IL213240A (en)	2015-04-30	Pharmacy composition containing poly-fluorescein conjugate
EG24357A (en)	2009-03-04	New Pharmaceutical composition
IL152659A0 (en)	2003-06-24	Pharmaceutical composition
SI1524266T1 (sl)	2007-08-31	Farmacevtski sestavek
HUP0204555A3 (en)	2004-06-28	Pharmaceutical composition
GB0006133D0 (en)	2000-05-03	Novel pharmaceutical
GB0009605D0 (en)	2000-06-07	Medicaments
GB0025473D0 (en)	2000-11-29	Pharmaceutical combinations
GB0002312D0 (en)	2000-03-22	Medicaments
IL154238A0 (en)	2003-09-17	Pharmaceutical composition
GB0026467D0 (en)	2000-12-13	Compound, composition and use
GB0024362D0 (en)	2000-11-22	Medicaments
MXPA03000975A (es)	2003-06-09	Composicion farmaceutica.
GB0015324D0 (en)	2000-08-16	Medicaments
ZA200109677B (en)	2002-06-25	A nutritional and pharmaceutical composition.
GB0005382D0 (en)	2000-04-26	Pharmaceutical composition
GB0014006D0 (en)	2000-08-02	Novel pharmaceutical
GB0021487D0 (en)	2000-10-18	Pharmaceutical
GB0014005D0 (en)	2000-08-02	Novel pharmaceutical
GB0019223D0 (en)	2000-09-27	Novel pharmaceutical
GB0002691D0 (en)	2000-03-29	Pharmaceutical composition
GB0101094D0 (en)	2001-02-28	Pharmaceutical composition
AUPQ875300A0 (en)	2000-08-03	A pharmaceutical composition
EG24200A (en)	2008-10-19	Novel pharmaceutical